Medications to control excessive production of cortisol at the adrenal gland include ketoconazole, mitotane (Lysodren) and metyrapone (Metopirone). Mifepristone (Korlym, Mifeprex) is approved for people with Cushing syndrome who have type 2 diabetes or glucose intolerance.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Cushing's Disease Treatment industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Ketoconazole
Mitotane
Aminoglutethimide
Metyrapone
Mifepristone
Etomidate
Pasireotide
Market Segment by Product Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Clinics
E-Commerce/Online Pharmacies
Finally, the report provides detailed profile and data information analysis of leading company.
CORCEPT THERAPEUTICS
HRA Pharma
Strongbridge Biopharma
Novartis
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Cushing's Disease Treatment consumption (value) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of Cushing's Disease Treatment market by identifying its various subsegments.
3.Focuses on the key global Cushing's Disease Treatment manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Cushing's Disease Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Cushing's Disease Treatment submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Cushing's Disease Treatment Market Research Report 2021, Forecast to 2026
1 Market Study Overview
1.1 Study Objectives
1.2 Cushing's Disease Treatment Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Cushing's Disease Treatment Segment by Type
2.1.1 Ketoconazole
2.1.2 Mitotane
2.1.3 Aminoglutethimide
2.1.4 Metyrapone
2.1.5 Mifepristone
2.1.6 Etomidate
2.1.7 Pasireotide
2.2 Market Analysis by Application
2.2.1 Hospital Pharmacies
2.2.2 Retail Pharmacies
2.2.3 Drug Stores
2.2.4 Clinics
2.2.5 E-Commerce/Online Pharmacies
2.3 Global Cushing's Disease Treatment Market Comparison by Regions (2016-2026)
2.3.1 Global Cushing's Disease Treatment Market Size (2016-2026)
2.3.2 North America Cushing's Disease Treatment Status and Prospect (2016-2026)
2.3.3 Europe Cushing's Disease Treatment Status and Prospect (2016-2026)
2.3.4 China Cushing's Disease Treatment Status and Prospect (2016-2026)
2.3.5 Japan Cushing's Disease Treatment Status and Prospect (2016-2026)
2.3.6 Southeast Asia Cushing's Disease Treatment Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Cushing's Disease Treatment Industry Impact
2.5.1 Cushing's Disease Treatment Business Impact Assessment - Covid-19
2.5.2 Market Trends and Cushing's Disease Treatment Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Cushing's Disease Treatment Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Cushing's Disease Treatment Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Cushing's Disease Treatment Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Cushing's Disease Treatment Manufacturer Market Share
3.5 Top 10 Cushing's Disease Treatment Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Cushing's Disease Treatment Market
3.7 Key Manufacturers Cushing's Disease Treatment Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Cushing's Disease Treatment Industry Key Manufacturers
4.1 CORCEPT THERAPEUTICS
4.1.1 Compan Detail
4.1.2 CORCEPT THERAPEUTICS Cushing's Disease Treatment Product Introduction, Application and Specification
4.1.3 CORCEPT THERAPEUTICS 133 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 CORCEPT THERAPEUTICS News
4.2 HRA Pharma
4.2.1 Compan Detail
4.2.2 HRA Pharma Cushing's Disease Treatment Product Introduction, Application and Specification
4.2.3 HRA Pharma Cushing's Disease Treatment Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 CORCEPT THERAPEUTICS News
4.3 Strongbridge Biopharma
4.3.1 Compan Detail
4.3.2 Strongbridge Biopharma Cushing's Disease Treatment Product Introduction, Application and Specification
4.3.3 Strongbridge Biopharma Cushing's Disease Treatment Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 Strongbridge Biopharma News
4.4 Novartis
4.4.1 Compan Detail
4.4.2 Novartis Cushing's Disease Treatment Product Introduction, Application and Specification
4.4.3 Novartis Cushing's Disease Treatment Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Novartis News
5 Global Cushing's Disease Treatment Market Segment by Big Type
5.1 Global Cushing's Disease Treatment Revenue, Sales and Market Share by Big Type (2016-2021)
5.1.1 Global Cushing's Disease Treatment Sales and Market Share by Big Type (2016-2021)
5.1.2 Global Cushing's Disease Treatment Revenue and Market Share by Big Type (2016-2021)
5.2 Ketoconazole Sales Growth Rate and Price
5.2.1 Global Ketoconazole Sales Growth Rate (2016-2021)
5.2.2 Global Ketoconazole Price (2016-2021)
5.3 Mitotane Sales Growth Rate and Price
5.3.1 Global Mitotane Sales Growth Rate (2016-2021)
5.3.2 Global Mitotane Price (2016-2021)
5.4 Aminoglutethimide Sales Growth Rate and Price
5.4.1 Global Aminoglutethimide Sales Growth Rate (2016-2021)
5.4.2 Global Aminoglutethimide Price (2016-2021)
5.5 Metyrapone Sales Growth Rate and Price
5.5.1 Global Metyrapone Sales Growth Rate (2016-2021)
5.5.2 Global Metyrapone Price (2016-2021)
5.6 Mifepristone Sales Growth Rate and Price
5.6.1 Global Mifepristone Sales Growth Rate (2016-2021)
5.6.2 Global Mifepristone Price (2016-2021)
5.7 Etomidate Sales Growth Rate and Price
5.7.1 Global Etomidate Sales Growth Rate (2016-2021)
5.7.2 Global Etomidate Price (2016-2021)
5.8 Pasireotide Sales Growth Rate and Price
5.8.1 Global Pasireotide Sales Growth Rate (2016-2021)
5.8.2 Global Pasireotide Price (2016-2021)
6 Global Cushing's Disease Treatment Market Segment by Big Application
6.1 Global Cushing's Disease Treatment Sales Market Share by Big Application (2016-2021)
6.2 Hospital Pharmacies Sales Growth Rate (2016-2021)
6.3 Retail Pharmacies Sales Growth Rate (2016-2021)
6.4 Drug Stores Sales Growth Rate (2016-2021)
6.5 Clinics Sales Growth Rate (2016-2021)
6.6 E-Commerce/Online Pharmacies Sales Growth Rate (2016-2021)
7 Global Cushing's Disease Treatment Forecast
7.1 Global Cushing's Disease Treatment Revenue, Sales and Growth Rate (2021-2026)
7.2 Cushing's Disease Treatment Market Forecast by Regions (2021-2026)
7.2.1 North America Cushing's Disease Treatment Market Forecast (2021-2026)
7.2.2 Europe Cushing's Disease Treatment Market Forecast (2021-2026)
7.2.3 China Cushing's Disease Treatment Market Forecast (2021-2026)
7.2.4 Japan Cushing's Disease Treatment Market Forecast (2021-2026)
7.2.5 Southeast Asia Cushing's Disease Treatment Market Forecast (2021-2026)
7.2.6 Other Regions Cushing's Disease Treatment Market Forecast (2021-2026)
7.3 Cushing's Disease Treatment Market Forecast by Type (2021-2026)
7.3.1 Global Cushing's Disease Treatment Sales Forecast by Type (2021-2026)
7.3.2 Global Cushing's Disease Treatment Market Share Forecast by Type (2021-2026)
7.4 Cushing's Disease Treatment Market Forecast by Application (2021-2026)
7.4.1 Global Cushing's Disease Treatment Sales Forecast by Application (2021-2026)
7.4.2 Global Cushing's Disease Treatment Market Share Forecast by Application (2021-2026)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Cushing's Disease Treatment Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Cushing's Disease Treatment Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Cushing's Disease Treatment
Figure Market Concentration Ratio and Market Maturity Analysis of Cushing's Disease Treatment
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Cushing's Disease Treatment Market Size by Big Type
Figure Global Market Share of Cushing's Disease Treatment by Big Type in 2020
Figure Ketoconazole Picture (2016-2021)
Figure Mitotane Picture (2016-2021)
Figure Aminoglutethimide Picture (2016-2021)
Figure Metyrapone Picture (2016-2021)
Figure Mifepristone Picture (2016-2021)
Figure Etomidate Picture (2016-2021)
Global Cushing's Disease Treatment Market Size by Big Application
Table Global Cushing's Disease Treatment Market Size by Application
Figure Global Cushing's Disease Treatment Market Share by Big Application in 2020
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Drug Stores Picture
Figure Clinics Picture
Figure E-Commerce/Online Pharmacies Picture
Table Global Cushing's Disease Treatment Comparison by Regions (M USD) ?2016-2026?
Figure Global Cushing's Disease Treatment Market Size (Million US$) (2016-2026)
Figure North America Cushing's Disease Treatment Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Cushing's Disease Treatment Revenue (Million US$) Growth Rate (2016-2026)
Figure China Cushing's Disease Treatment Revenue (Million US$) Growth Rate (2016-2026)
Figure Japan Cushing's Disease Treatment Revenue (Million US$) Growth Rate (2016-2026)
Figure Southeast Asia Cushing's Disease Treatment Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Cushing's Disease Treatment Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Cushing's Disease Treatment Sales by Manufacturer (2016-2021)
Figure Global Cushing's Disease Treatment Sales Market Share by Manufacturer in 2020
Table Global Cushing's Disease Treatment Revenue by Manufacturer (2016-2021)
Figure Global Cushing's Disease Treatment Revenue Market Share by Manufacturer in 2020
Table Global Cushing's Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Cushing's Disease Treatment Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Cushing's Disease Treatment Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Cushing's Disease Treatment Market
Table Key Manufacturers Cushing's Disease Treatment Product Type
Table Mergers & Acquisitions Planning
Table CORCEPT THERAPEUTICS Company Profile
Table Cushing's Disease Treatment Product Introduction, Application and Specification of CORCEPT THERAPEUTICS
Table Cushing's Disease Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2016-2021
Table Company One Main Business
Table Company One Recent Development
Table HRA Pharma Company Profile
Table Cushing's Disease Treatment Product Introduction, Application and Specification of HRA Pharma
Table Cushing's Disease Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table HRA Pharma Recent Development
Table Strongbridge Biopharma Company Profile
Table Cushing's Disease Treatment Product Introduction, Application and Specification of Strongbridge Biopharma
Table Cushing's Disease Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Strongbridge Biopharma Main Business
Table Strongbridge Biopharma Recent Development
Table Novartis Company Profile
Table Cushing's Disease Treatment Product Introduction, Application and Specification of Novartis
Table Cushing's Disease Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Novartis Main Business
Table Novartis Recent Development
Table Novartis Main Business
Table Novartis Recent Development
Figure Global Cushing's Disease Treatment Sales and Growth Rate (2016-2021)
Figure Global Cushing's Disease Treatment Revenue and Growth Rate (2016-2021)
Table Global Cushing's Disease Treatment Sales by Regions (2016-2021)
Figure Global Cushing's Disease Treatment Sales Market Share by Regions in 2020
Table Global Cushing's Disease Treatment Revenue by Regions (2016-2021)
Figure Global Cushing's Disease Treatment Revenue Market Share by Regions in 2020
Figure North America Cushing's Disease Treatment Sales and Growth Rate (2016-2021)
Figure Europe Cushing's Disease Treatment Sales and Growth Rate (2016-2021)
Figure China Cushing's Disease Treatment Sales and Growth Rate (2016-2021)
Figure Japan Cushing's Disease Treatment Sales and Growth Rate (2016-2021)
Figure Southeast Asia Cushing's Disease Treatment Sales and Growth Rate (2016-2021)
Figure Other Regions Cushing's Disease Treatment Sales and Growth Rate (2016-2021)
Table Global Cushing's Disease Treatment Sales by Big Type (2016-2021)
Table Global Cushing's Disease Treatment Sales Market Share by Big Type (2016-2021)
Figure Global Cushing's Disease Treatment Sales Market Share by Big Type in 2019
Table Global Cushing's Disease Treatment Revenue by Big Type (2016-2021)
Table Global Cushing's Disease Treatment Revenue Market Share by Big Type (2016-2021)
Table Global Cushing's Disease Treatment Revenue Market Share by Big Type in 2019
Figure Global Ketoconazole Sales Growth Rate (2016-2021)
Figure Global Ketoconazole Price (2016-2021)
Figure Global Mitotane Sales Growth Rate (2016-2021)
Figure Global Mitotane Price (2016-2021)
Figure Global Aminoglutethimide Sales Growth Rate (2016-2021)
Figure Global Aminoglutethimide Price (2016-2021)
Figure Global Metyrapone Sales Growth Rate (2016-2021)
Figure Global Metyrapone Price (2016-2021)
Figure Global Etomidate Sales Growth Rate (2016-2021)
Figure Global Etomidate Price (2016-2021)
Figure Global Pasireotide Sales Growth Rate (2016-2021)
Table Global Cushing's Disease Treatment Sales by Big Application (2016-2021)
Table Global Cushing's Disease Treatment Sales Market Share by Big Application (2016-2021)
Figure Global Cushing's Disease Treatment Sales Market Share by Big Application in 2019
Figure Global Hospital Pharmacies Sales Growth Rate (2016-2021)
Figure Global Retail Pharmacies Sales Growth Rate (2016-2021)
Figure Global Drug Stores Sales Growth Rate (2016-2021)
Figure Global Clinics Sales Growth Rate (2016-2021)
Figure Global E-Commerce/Online Pharmacies Sales Growth Rate (2016-2021)
Figure Global Cushing's Disease Treatment Sales and Growth Rate (2021-2026)
Figure Global Cushing's Disease Treatment Revenue and Growth Rate (2021-2026)
Table Global Cushing's Disease Treatment Sales Forecast by Regions (2021-2026)
Table Global Cushing's Disease Treatment Market Share Forecast by Regions (2021-2026)
Figure North America Sales Cushing's Disease Treatment Market Forecast (2021-2026)
Figure Europe Sales Cushing's Disease Treatment Market Forecast (2021-2026)
Figure China Sales Cushing's Disease Treatment Market Forecast (2021-2026)
Figure Japan Sales Cushing's Disease Treatment Market Forecast (2021-2026)
Figure Southeast Asia Sales Cushing's Disease Treatment Market Forecast (2021-2026)
Figure Other Regions Sales Cushing's Disease Treatment Market Forecast (2021-2026)
Table Global Cushing's Disease Treatment Sales Forecast by Type (2021-2026)
Table Global Cushing's Disease Treatment Market Share Forecast by Type (2021-2026)
Table Global Cushing's Disease Treatment Sales Forecast by Application (2021-2026)
Table Global Cushing's Disease Treatment Market Share Forecast by Application (2021-2026)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cushing's Disease Treatment
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Cushing's Disease Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Cushing's Disease Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Cushing's Disease Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Cushing's Disease Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Cushing's Disease Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Cushing's Disease Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Cushing's Disease Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Cushing's Disease Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
CORCEPT THERAPEUTICS
HRA Pharma